日本的成问题:一个区域视角
Soichiro Ide1, Yoko Nishitani2, Masahiko Sumitani3
1Addictive Substance Project, Tokyo Metropolitan Institute of Medical Science, Tokyo, Japan.
Addiction (Abingdon, England)
|December 31, 2025
概括
日本面临着一个独特的成挑战:低水平的非法药物使用与高水平的酒精,烟草和博危害形成鲜明对比. 最近的趋势显示大麻犯罪的增加,突出显示不断发展的毒品问题以及持续的行为上.
科学领域:
- 药物成科学 药物成科学
- 公共卫生 公共卫生
- 流行病学 流行病学
背景情况:
- 日本的非法药物使用率很低,但与酒精,烟草和博有关的伤害率很高.
- 从历史上看,甲基胺主导着毒品犯罪,但大麻犯罪在2023年超过了兴奋剂犯罪.
研究的目的:
- 审查日本与毒品有关的问题,涵盖流行病学,社会影响,政策,预防和治疗.
- 分析当前的成科学趋势,并提出政策与研究的整合.
主要方法:
- 关于日本成风景的文学评论.
- 对流行病学数据和政策变化的分析.
- 检查社会影响和治疗基础设施.
主要成果:
- 在成年人中,非法药物使用率仍低于3%.
- 过度饮酒,吸烟和数字化博障碍造成了严重的疾病负担.
- 自1958年以来,大麻犯罪首次超过了兴奋剂犯罪.
结论:
- 日本的成概况的特点是非法药物使用率低,合法物质和行为成的流行率高.
- 国家的做法平衡了严格的执法与以健康为中心的护理,为类似地区提供了潜在的模型.
- 整合政策和研究对于有效应对复杂的成挑战至关重要.
相关概念视频
Drug Abuse and Addiction: Pharmacological Phenomena
1.1K
Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not...
1.1K
Drug Dependence
1.5K
Medications are typically administered to achieve therapeutic effects. Some drugs can modify an individual's mood and perception, frequently resulting in various enjoyable experiences. However, this can result in drug dependency, a condition marked by continuous drug use despite potential negative consequences. Drug dependency primarily falls into two categories: psychological and physical dependence. Psychological dependence occurs when the pleasurable feelings induced by the drug...
1.5K
Substance Use Disorders Affecting Sleep
360
Substance use disorders involve a pattern of using drugs more extensively than intended and continuing use despite harmful consequences. This includes legal substances like alcohol and nicotine, as well as illegal drugs. These disorders often involve both physical and psychological dependence, reflecting compulsive use of substances that significantly alter thoughts, feelings, and behaviors, contributing to a major public health issue.
Understanding the concepts of physical dependence,...
Understanding the concepts of physical dependence,...
360
CNS Depressants: Alcohol and Nicotine
984
Ethanol, a clear colorless alcohol, has been consumed by humans for millennia, but its effects on the body are far from benign. At lower doses, it induces decreased inhibitions and loquaciousness, leading to its social appeal. However, it can cause severe consequences at higher doses, such as coma and respiratory depression, due to its zero-order elimination kinetics. Chronic ethanol abuse wreaks havoc on multiple organ systems, particularly the CNS and the liver. Abrupt cessation of ethanol...
984
Stimulants
802
Stimulants are substances that enhance neural activity and elevate dopamine levels in the brain, leading to their highly addictive nature. These drugs include cocaine, amphetamines, MDMA, caffeine, and nicotine, each with distinct mechanisms of action and varied health implications.
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
802
Drug Control Governance: Regulatory Bodies and Their Impact
461
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
461


